| Membrane transporters in drug development Nature reviews Drug discovery 9 (3), 215-236, 2010 | 3562 | 2010 |
| Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine M Drozdzik, C Gröer, J Penski, J Lapczuk, M Ostrowski, Y Lai, B Prasad, ... Molecular pharmaceutics 11 (10), 3547-3555, 2014 | 280 | 2014 |
| Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters M Leonhardt, M Keiser, S Oswald, J Kühn, J Jia, M Grube, HK Kroemer, ... Drug metabolism and disposition 38 (7), 1024-1028, 2010 | 278 | 2010 |
| Organic anion transporting polypeptide 2B1 is a high‐affinity transporter for atorvastatin and is expressed in the human heart M Grube, K Köck, S Oswald, K Draber, K Meissner, L Eckel, M Böhm, ... Clinical Pharmacology & Therapeutics 80 (6), 607-620, 2006 | 257 | 2006 |
| Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid–enhanced MR imaging A Nassif, J Jia, M Keiser, S Oswald, C Modess, S Nagel, W Weitschies, ... Radiology 264 (3), 741-750, 2012 | 161 | 2012 |
| LC–MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins C Gröer, S Brück, Y Lai, A Paulick, A Busemann, CD Heidecke, ... Journal of pharmaceutical and biomedical analysis 85, 253-261, 2013 | 153 | 2013 |
| Protein abundance of clinically relevant drug‐metabolizing enzymes in the human liver and intestine: a comparative analysis in paired tissue specimens M Drozdzik, D Busch, J Lapczuk, J Müller, M Ostrowski, M Kurzawski, ... Clinical pharmacology & therapeutics 104 (3), 515-524, 2018 | 133 | 2018 |
| Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade LI Partecke, S Speerforck, A Käding, F Seubert, S Kühn, E Lorenz, ... Pancreatology 16 (3), 423-433, 2016 | 131 | 2016 |
| Intestinal expression of P‐glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate–glucuronosyltransferase 1A1 … S Oswald, S Haenisch, C Fricke, T Sudhop, C Remmler, T Giessmann, ... Clinical Pharmacology & Therapeutics 79 (3), 206-217, 2006 | 122 | 2006 |
| Protein abundance of clinically relevant drug transporters in the human liver and intestine: a comparative analysis in paired tissue specimens M Drozdzik, D Busch, J Lapczuk, J Müller, M Ostrowski, M Kurzawski, ... Clinical Pharmacology & Therapeutics 105 (5), 1204-1212, 2019 | 118 | 2019 |
| Variability in mass spectrometry-based quantification of clinically relevant drug transporters and drug metabolizing enzymes C Wegler, FZ Gaugaz, TB Andersson, JR Wiśniewski, D Busch, C Gröer, ... Molecular pharmaceutics 14 (9), 3142-3151, 2017 | 113 | 2017 |
| Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1 S Oswald, J König, D Lütjohann, T Giessmann, HK Kroemer, C Rimmbach, ... Pharmacogenetics and genomics 18 (7), 559-568, 2008 | 112 | 2008 |
| A LC–MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1 S Oswald, E Scheuch, I Cascorbi, W Siegmund Journal of Chromatography B 830 (1), 143-150, 2006 | 102 | 2006 |
| Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics C Gröer, D Busch, M Patrzyk, K Beyer, A Busemann, CD Heidecke, ... Journal of pharmaceutical and biomedical analysis 100, 393-401, 2014 | 99 | 2014 |
| Expression, regulation and function of intestinal drug transporters: an update J Müller, M Keiser, M Drozdzik, S Oswald Biological chemistry 398 (2), 175-192, 2017 | 95 | 2017 |
| Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin J Niessen, G Jedlitschky, M Grube, S Bien, H Schwertz, S Ohtsuki, ... Drug Metabolism and Disposition 37 (5), 1129-1137, 2009 | 75 | 2009 |
| Caco‐2 cells–expression, regulation and function of drug transporters compared with human jejunal tissue S Brück, J Strohmeier, D Busch, M Drozdzik, S Oswald Biopharmaceutics & drug disposition 38 (2), 115-126, 2017 | 71 | 2017 |
| Targeted adsorption of molecules in the colon with the novel adsorbent‐based Medicinal Product, DAV132: A proof of concept study in healthy subjects J de Gunzburg, A Ducher, C Modess, D Wegner, S Oswald, J Dressman, ... The Journal of Clinical Pharmacology 55 (1), 10-16, 2015 | 70 | 2015 |
| Pharmaceutical excipients influence the function of human uptake transporting proteins A Engel, S Oswald, W Siegmund, M Keiser Molecular pharmaceutics 9 (9), 2577-2581, 2012 | 70 | 2012 |
| Expression of clinically relevant drug‐metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra‐subject analysis A Fritz, D Busch, J Lapczuk, M Ostrowski, M Drozdzik, S Oswald Basic & clinical pharmacology & toxicology 124 (3), 245-255, 2019 | 67 | 2019 |
